New Anti-Obesity Medications Should Be Consider...

By Staff Writer

August 6, 2024

Introduction Federal policymakers are evaluating a new class of drugs for managing and preventing type 2 diabetes symptoms. These medications, known as glucagon-like peptide-1 (GLP-1) receptor agonists, have shown unexpected success in w...